Share：
Share this content in WeChat
X
[Chinese][PDF]6103
• Reviews •
Clinical research progress of abbreviated breast MRI in breast cancer
WANG Yumei  TIAN Jiahe  ZHANG Lina  WANG Jian 

Cite this article as: WANG Y M, TIAN J H, ZHANG L N, et al. Clinical research progress of abbreviated breast MRI in breast cancer[J]. Chin J Magn Reson Imaging, 2023, 14(7): 186-191. DOI:10.12015/issn.1674-8034.2023.07.034.


[Abstract] Breast cancer is the most common malignant tumor in women, and the incidence of breast cancer is increasing year by year, which seriously threatens women's life and health. Early diagnosis and treatment are very important to improve the quality of life of breast cancer patients. Conventional multi-sequence MRI is expensive and takes a long time for scanning, post-processing and reading by physicians, which limits the wide application of MRI in clinical practice. Abbreviated breast MRI (AB-MRI) is expected to solve practical clinical problems. AB-MRI protocol is more acceptable to patients and has a promising future as a screening method for breast cancer. So far, the preoperative application of AB-MRI to evaluate the degree of breast cancer disease and neoadjuvant chemotherapy response is still insufficient, and more large-scale prospective studies are still needed. This paper summarizes the concept of AB-MRI, its sequence design and clinical application. It includes the screening of breast cancer in different risk groups, the differentiation of benign and malignant breast tumors, the preoperative staging of breast cancer, and the evaluation of response to neoadjuvant chemotherapy and other clinical applications. The purpose is to help radiologists strengthen their understanding and application of AB-MRI scheme, and help improve the level of accurate diagnosis and treatment of breast cancer.
[Keywords] breast cancer；magnetic reonance imaging；abbreviated breast MRI；breast cancer screening；tumor staging；neoadjuvant chemotherapy

WANG Yumei1, 2   TIAN Jiahe3   ZHANG Lina1*   WANG Jian2  

1 Department of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China

2 Department of Imaging, the First People's Hospital of Jinzhou District, Dalian 116100, China

3 Zhongshan College of Dalian Medical University, Dalian 116085, China

Corresponding author: Zhang LN, E-mail: zln201045@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS Continuing Education Teaching Reform Research project of Liaoning Adult Education Association (No. LCYJGZXYB22100); General Project of "Peak Climbing Plan" of Dalian City Key Specialty of Medicine (No. 2022DF042); General Project of Teaching Reform Research of Dalian Medical University (No. DYLX21036).
Received  2022-11-12
Accepted  2023-04-11
DOI: 10.12015/issn.1674-8034.2023.07.034
Cite this article as: WANG Y M, TIAN J H, ZHANG L N, et al. Clinical research progress of abbreviated breast MRI in breast cancer[J]. Chin J Magn Reson Imaging, 2023, 14(7): 186-191. DOI:10.12015/issn.1674-8034.2023.07.034.

[1]
ZHANG Y C, LYU Z Y, SONG F F, et al. Trends of incidence and mortality of breast cancer worldwide and in China[J]. J Multidiscip Cancer Manag Electron Version, 2021, 7(2): 14-20. DOI: 10.12151/JMCM.2021.02-02.
[2]
Breast cancer Professional Committee of China Anti Cancer Association. Guidelines and norms for diagnosis and treatment of breast cancer of China Anti-Cancer Association (2021 edition)[J]. China Oncol, 2021, 31(10): 954-1040. DOI: 10.19401/j.cnki.1007-3639.2021.10.013.
[3]
PETRILLO A, FUSCO R, SANSONE M, et al. Abbreviated breast dynamic contrast-enhanced MR imaging for lesion detection and characterization: the experience of an Italian oncologic center[J]. Breast Cancer Res Treat, 2017, 164(2): 401-410. DOI: 10.1007/s10549-017-4264-y.
[4]
KWON M R, CHOI J S, WON H, et al. Breast cancer screening with abbreviated breast MRI: 3-year outcome analysis[J]. Radiology, 2021, 299(1): 73-83. DOI: 10.1148/radiol.2021202927.
[5]
WEINSTEIN S P, KORHONEN K, CIRELLI C, et al. Abbreviated breast magnetic resonance imaging for supplemental screening of women with dense breasts and average risk[J]. J Clin Oncol, 2020, 38(33): 3874-3882. DOI: 10.1200/JCO.19.02198.
[6]
HARVEY S C, DI CARLO P A, LEE B, et al. An abbreviated protocol for high-risk screening breast MRI saves time and resources[J]. J Am Coll Radiol, 2016, 13(11S): R74-R80. DOI: 10.1016/j.jacr.2016.09.031.
[7]
YOUNG M, KIM, MD P, et al. Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with a history of breast cancer[J]. Acad Radiol, 2022, 29(10): 1458-1465. DOI: 10.1016/j.acra.2021.12.013.
[8]
PARK K W, HAN S B, HAN B K, et al. MRI surveillance for women with a personal history of breast cancer: comparison between abbreviated and full diagnostic protocol[J/OL]. Br J Radiol, 2020, 93(1106): 20190733 [2022-10-20]. https://sci-hub.wf/10.1259/bjr.20190733. DOI: 10.1259/bjr.20190733.
[9]
WAHAB R A, ALBASHA H, MARTIN J, et al. Characterization of common breast MRI abnormalities: comparison between abbreviated and full MRI protocols[J]. Clin Imaging, 2021, 79: 125-132. DOI: 10.1016/j.clinimag.2021.04.013.
[10]
VILAR V S, GOMES A I, FEDERICCI É E F, et al. FAST breast magnetic resonance imaging: a new approach for breast cancer screening?[J/OL]. Einstein (Sao Paulo), 2022, 20: eAO0073 [2022-10-20]. https://www.scielo.br/j/eins/a/s3sWF4xPRBxkRr9B6MNjfvK/?lang=en. DOI: 10.31744/einstein_journal/2022AO0073.
[11]
GIROMETTI R, NITTI A, LORENZON M, et al. Comparison between an abbreviated and full MRI protocol for detecting additional disease when doing breast cancer staging[J/OL]. J Magn Reson Imaging, 2019, 49(7): e222-e230 [2022-10-20]. https://onlinelibrary.wiley.com/doi/10.1002/jmri.26339. DOI: 10.1002/jmri.26339.
[12]
HYLTON N M. Residual disease after neoadjuvant therapy for breast cancer: can MRI help?[J]. Radiology, 2018, 289(2): 335-336. DOI: 10.1148/radiol.2018181846.
[13]
NIE Y, HE Y J, WANG J Z, et al. MRI images-based evaluation of efficacy of neoadjuvant chemotherapy for breast cancer and its effect on depression and immune function of patients[J/OL]. Contrast Media Mol Imaging, 2022, 2022: 8685680 [2022-12-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467715/. DOI: 10.1155/2022/8685680.
[14]
SHAO Z M, JIANG Z F, LI J J, et al. Expert consensus on neoadjuvant therapy for breast cancer in China (2019 edition)[J]. China Oncol, 2019, 29(5): 390-400. DOI: 10.19401/j.cnki.1007-3639.2019.05.009.
[15]
KUHL C K, SCHRADING S, STROBEL K, et al. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI[J]. J Clin Oncol, 2014, 32(22): 2304-2310. DOI: 10.1200/JCO.2013.52.5386.
[16]
KUHL C K. Abbreviated magnetic resonance imaging (MRI) for breast cancer screening: rationale, concept, and transfer to clinical practice[J]. Annu Rev Med, 2019, 70: 501-519. DOI: 10.1146/annurev-med-121417-100403.
[17]
HEACOCK L, MELSAETHER A N, HELLER S L, et al. Evaluation of a known breast cancer using an abbreviated breast MRI protocol: correlation of imaging characteristics and pathology with lesion detection and conspicuity[J]. Eur J Radiol, 2016, 85(4): 815-823. DOI: 10.1016/j.ejrad.2016.01.005.
[18]
STRAHLE D A, PATHAK D R, SIERRA A, et al. Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging[J]. Breast Cancer Res Treat, 2017, 162(2): 283-295. DOI: 10.1007/s10549-017-4112-0.
[19]
DOGAN B E, SCOGGINS M E, SON J B, et al. American college of radiology-compliant short protocol breast MRI for high-risk breast cancer screening: a prospective feasibility study[J]. AJR Am J Roentgenol, 2018, 210(1): 214-221. DOI: 10.2214/AJR.17.18267.
[20]
KWON M R, KO E Y, HAN B K, et al. Diagnostic performance of abbreviated breast MRI for screening of women with previously treated breast cancer[J/OL]. Medicine (Baltimore), 2020, 99(16): e19676 [2022-12-20]. https://journals.lww.com/md-journal/Fulltext/2020/04170/Diagnostic_performance_of_abbreviated_breast_MRI.25.aspx. DOI: 10.1097/MD.0000000000019676.
[21]
COMSTOCK C E, GATSONIS C, NEWSTEAD G M, et al. Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening[J]. JAMA, 2020, 323(8): 746-756. DOI: 10.1001/jama.2020.0572.
[22]
MILON A, VANDE PERRE S, POUJOL J, et al. Abbreviated breast MRI combining FAST protocol and high temporal resolution (HTR) dynamic contrast enhanced (DCE) sequence[J]. Eur J Radiol, 2019, 117: 199-208. DOI: 10.1016/j.ejrad.2019.06.022.
[23]
KUL S, METIN Y, BEKIRCAVUSOGLU S, et al. Qualitative characterization of breast tumors with diffusion-weighted imaging has comparable accuracy to quantitative analysis[J]. Clin Imaging, 2021, 77: 17-24. DOI: 10.1016/j.clinimag.2021.02.025.
[24]
OHLMEYER S, LAUN F B, BICKELHAUPT S, et al. Ultra-high b-value diffusion-weighted imaging-based abbreviated protocols for breast cancer detection[J]. Invest Radiol, 2021, 56(10): 629-636. DOI: 10.1097/RLI.0000000000000784.
[25]
SHAO Z Z, LIU P F, ZHANG S P, et al. Abbreviated protocol combining quantitative diffusion-weighted imaging: a new strategy increasing diagnostic accuracy for breast magnetic resonance imaging?[J]. Gland Surg, 2021, 10(9): 2705-2714. DOI: 10.21037/gs-21-463.
[26]
PLATEL B, MUS R, WELTE T, et al. Automated characterization of breast lesions imaged with an ultrafast DCE-MR protocol[J]. IEEE Trans Med Imaging, 2014, 33(2): 225-232. DOI: 10.1109/TMI.2013.2281984.
[27]
MUS R D, BORELLI C, BULT P, et al. Time to enhancement derived from ultrafast breast MRI as a novel parameter to discriminate benign from malignant breast lesions[J]. Eur J Radiol, 2017, 89: 90-96. DOI: 10.1016/j.ejrad.2017.01.020.
[28]
JEONG S M, HA S M, AHN H S, et al. A preliminary study of the combination of ultrafast and abbreviated dynamic contrast: enhanced breast magnetic resonance imaging[J/OL]. Medicine, 2020, 99(50): e23415 [2022-10-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738033/. DOI: 10.1097/MD.0000000000023415.
[29]
FONSECA M M, ALHASSAN T, NISHA Y, et al. Randomized trial of surveillance with abbreviated MRI in women with a personal history of breast cancer-impact on patient anxiety and cancer detection[J/OL]. BMC Cancer, 2022, 22(1): 774 [2022-10-20]. https://bmccancer.biomedcentral.com/articles/10.1186/s12885-022-09792-x. DOI: 10.1186/s12885-022-09792-x.
[30]
OLDRINI G, DERRAZ I, SALLERON J, et al. Impact of an abbreviated protocol for breast MRI in diagnostic accuracy[J]. Diagn Interv Radiol, 2018, 24(1): 12-16. DOI: 10.5152/dir.2018.16609.
[31]
AHMADINEJAD N, AZHDEH S, ARIAN A, et al. Implementation of abbreviated breast MRI in diagnostic and screening settings[J]. Acta Radiol, 2023, 64(3): 987-992. DOI: 10.1177/02841851221114434.
[32]
KENNARD K, WANG O, KJELSTROM S, et al. Outcomes of abbreviated MRI (ab-MRI) for women of any breast cancer risk and breast density in a community academic setting[J]. Ann Surg Oncol, 2022, 29(10): 6215-6221. DOI: 10.1245/s10434-022-12194-9.
[33]
NARANJO I D, SOGANI J, SACCARELLI C, et al. MRI screening of BRCA mutation carriers: comparison of standard protocol and abbreviated protocols with and without T2-weighted images[J]. AJR Am J Roentgenol, 2022, 218(5): 810-820. DOI: 10.2214/AJR.21.27022.
[34]
OSEI K V, MEHTA A K, THIGPEN D M, et al. Abbreviated breast MRI for screening high-risk women: comparison with the full clinical protocol[J]. J Breast Imaging, 2021, 3(2): 196-200. DOI: 10.1093/jbi/wbaa101.
[35]
CHOI B H, CHOI N, KIM M Y, et al. Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery[J]. Breast Cancer Res Treat, 2018, 167(2): 495-502. DOI: 10.1007/s10549-017-4530-z.
[36]
KIM M Y, SUH Y J, AN Y Y. Imaging surveillance for the detection of ipsilateral local tumor recurrence in patients who underwent oncoplastic breast-conserving surgery with acellular dermal matrix: abbreviated MRI versus conventional mammography and ultrasonography[J/OL]. World J Surg Oncol, 2021, 19(1): 290 [2022-10-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477561/. DOI: 10.1186/s12957-021-02403-2.
[37]
BAEK S J, KO K H, JUNG H K, et al. Comparison of abbreviated MRI with mammography and ultrasound in women with a personal history of breast cancer[J]. Acad Radiol, 2022, 29(Suppl 1): S19-S25. DOI: 10.1016/j.acra.2021.05.022.
[38]
ZHAO X, YUAN L, ZHANG C, et al. Quantitative value of DCE-MRI perfusion parameters in distinguishing benign and malignant breast lesions[J]. J Clin Radiol, 2022, 41(5): 834-838. DOI: 10.13437/j.cnki.jcr.2022.05.014.
[39]
KIM E S, CHO N, KIM S Y, et al. Comparison of abbreviated MRI and full diagnostic MRI in distinguishing between benign and malignant lesions detected by breast MRI: a multireader study[J]. Korean J Radiol, 2021, 22(3): 297-307. DOI: 10.3348/kjr.2020.0311.
[40]
FARGHADANI M, KHATAEI J, FOSOULI M, et al. Comparison of diagnostic values of two magnetic resonance imaging (MRI) protocols for diagnosis of breast lesions[J/OL]. Int J Physiol Pathophysiol Pharmacol, 2022, 14(3): 193-199 [2022-10-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301178/.
[41]
MANN R M, VAN ZELST J C M, VREEMANN S, et al. Is ultrafast or abbreviated breast MRI ready for prime time?[J]. Curr Breast Cancer Rep, 2019, 11(1): 9-16. DOI: 10.1007/s12609-019-0300-8.
[42]
OLDRINI G, FEDIDA B, POUJOL J, et al. Abbreviated breast magnetic resonance protocol: value of high-resolution temporal dynamic sequence to improve lesion characterization[J]. Eur J Radiol, 2017, 95: 177-185. DOI: 10.1016/j.ejrad.2017.07.025.
[43]
STEPHANIE L F, MELISSA J, LINDSEY S, et al. Abbreviated breast MRI for estimating extent of disease in newly diagnosed breast cancer[J]. J Breast Imaging, 2020, 2(1): 43-49. DOI: 10.1093/jbi/wbz071.
[44]
CHEN P P, SHAO G R, LI B J, et al. Performance of abbreviated protocols versus unenhanced MRI in detecting occult breast lesions of mammography in patients with dense breasts[J/OL]. Sci Rep, 2022, 12(1): 13660 [2022-10-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372172/. DOI: 10.1038/s41598-022-17945-y.
[45]
SHIRAISHI M, IGARASHI T, TERAYAMA T, et al. Breast magnetic resonance imaging for estimation of the tumour extent in patients with pure ductal carcinoma in situ: comparison between full diagnostic and abbreviated protocols[J/OL]. Eur J Radiol, 2020, 123: 108788 [2022-10-20]. https://pubmed.ncbi.nlm.nih.gov/31874302/. DOI: 10.1016/j.ejrad.2019.108788.
[46]
LIU Z S, LI X P, FENG B, et al. MIP image derived from abbreviated breast MRI: potential to reduce unnecessary sub-nipple biopsies during nipple-sparing mastectomy for breast cancer[J]. Eur Radiol, 2021, 31(6): 3683-3692. DOI: 10.1007/s00330-020-07550-w.
[47]
CHANG L F, LAN H L. Effect of neoadjuvant chemotherapy on angiogenesis and cell proliferation of breast cancer evaluated by dynamic enhanced magnetic resonance imaging[J/OL]. Biomed Res Int, 2022, 2022: 3156093 [2022-10-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338867/. DOI: 10.1155/2022/3156093.
[48]
YIRGIN I K, ENGIN G, YILDIZ Ş, et al. Abbreviated and standard breast MRI in neoadjuvant chemotherapy response evaluation: a comparative study[J]. Curr Med Imaging, 2022, 18(10): 1052-1060. DOI: 10.2174/1573405618666220223142009.
[49]
TANG W J, CHEN S Y, HU W K, et al. Abbreviated versus full-protocol MRI for breast cancer neoadjuvant chemotherapy response assessment: diagnostic performance by general and breast radiologists[J/OL]. AJR Am J Roentgenol, 2023 [2023-03-06]. https://www.ajronline.org/doi/suppl/10.2214/AJR.22.28686. DOI: 10.2214/AJR.22.28686.
[50]
BI W L, HOSNY A, SCHABATH M B, et al. Artificial intelligence in cancer imaging: clinical challenges and applications[J]. CA Cancer J Clin, 2019, 69(2): 127-157. DOI: 10.3322/caac.21552.
[51]
MCKINNEY S M, SIENIEK M, GODBOLE V, et al. International evaluation of an AI system for breast cancer screening[J]. Nature, 2020, 577(7788): 89-94. DOI: 10.1038/s41586-019-1799-6.
[52]
HUSSAIN L, HUANG P, NGUYEN T, et al. Machine learning classification of texture features of MRI breast tumor and peri-tumor of combined pre- and early treatment predicts pathologic complete response[J/OL]. Biomed Eng Online, 2021, 20(1): 63 [2022-10-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240261/. DOI: 10.1186/s12938-021-00899-z.

PREV Current status and progress in predicting the efficacy of neoadjuvant therapy for breast cancer based on MRI radiomics methods
NEXT Progressions in clinical application of magnetic resonance imaging in myopathy
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn